Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 124, 2018 - Issue 1
320
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Carbonic anhydrase I–II autoantibodies and oxidative status in long-term follow-up of patients with Crimean–Congo haemorrhagic fever

, , , , , , , & show all
Pages 69-74 | Received 11 Jun 2017, Accepted 26 Jul 2017, Published online: 10 Aug 2017

References

  • Adamus, G., 2009. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmunity reviews, 8, 410–414.
  • Alver, A., et al., 2007. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Experimental and clinical endocrinology & diabetes: official journal, German society of endocrinology [and] German diabetes association, 115, 287–291.
  • Alver, A., et al., 2011. Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clinical biochemistry, 44, 1385–1389.
  • Amara, A., et al., 1995. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clinical and experimental immunology, 101, 233–238.
  • Aydin, H., et al., 2013. Oxidative stress in the adult and pediatric patients with Crimean–Congo haemorrhagic fever. Journal of vector borne diseases, 50, 297–301.
  • Aydin, H., et al., 2010. Malondialdehyde, vitamin E, and anti-oxidant enzyme activity levels in patients with Crimean-Congo hemorrhagic fever. African journal of microbiology research, 4, 2402–2409.
  • Ben, M.R., et al., 2010. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scandinavian journal of rheumatology, 39, 247–253.
  • Bente, D.A., et al., 2013. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral research, 100, 159–189.
  • Cevik, M.A., et al., 2008. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. International journal of infectious diseases, 12, 374–379.
  • Connolly-Andersen, A.M., et al., 2011. Crimean-Congo hemorrhagic fever virus activates endothelial cells. Journal of virology, 85, 7766–7774.
  • Cvetkovic, J.T., et al., 2002. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis. Rheumatology (Oxford, England), 41, 988–995.
  • Ergonul, O., et al., 2006. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clinical microbiology and infection, 12, 551–554.
  • Ergonul, O., et al., 2004. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clinical infectious diseases, 39, 284–287.
  • Guner, R., et al., 2012. Relationship between total thiol status and thrombocytopenia in patients with Crimean-Congo hemorrhagic fever. The Southeast Asian journal of tropical medicine and public health, 43, 1411–1418.
  • Halliwell, B. and Aruoma, O.I., 1991. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS letters, 281, 9–19.
  • Kadanali, A., Ozden, K., and Erol, S., 2012. Crimean-Congo hemorrhagic fever virus infection: clinical and laboratory observations and predictors of fatality. Turkiye Klinikleri journal of medical sciences, 32, 432–437.
  • Karadag, O.E., et al., 2014. Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever. Japanese journal of infectious diseases, 67, 22–26.
  • Kilic, E., et al., 2003. Serum malondialdehyde level in patients infected with Ascaris lumbricoides. World journal of gastroenterology, 9, 2332–2334.
  • Kuloglu, M., et al., 2002. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology, 46, 186–189.
  • Mentese, A., et al., 2013. Diagnostic and prognostic value of ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever. Journal of medical virology, 85, 684–688.
  • Pisoschi, A.M. and Pop, A., 2015. The role of antioxidants in the chemistry of oxidative stress: a review. European journal of medicinal chemistry, 97, 55–74.
  • Ryan, B.J., Nissim, A., and Winyard, P.G., 2014. Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox biology, 2, 715–724.
  • Salonen, J., et al., 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet (London, England), 339, 883–887.
  • Sfriso, P., et al., 2010. Infections and autoimmunity: the multifaceted relationship. Journal of leukocyte biology, 87, 385–395.
  • Supuran, C.T., 2008. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature reviews. Drug discovery, 7, 168–181.
  • Swanepoel, R., et al., 1989. The clinical pathology of Crimean-Congo hemorrhagic fever. Reviews of infectious diseases, 11, 794–800.
  • Tezer, H. and Polat, M., 2015. Diagnosis of Crimean-Congo hemorrhagic fever. Expert review of anti-infective therapy, 13, 555–566.
  • Toyoda, K., et al., 2007. Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of anti-DNA response. The journal of biological chemistry, 282, 25769–25778.
  • Uchida, K., Hasui, Y., and Osawa, T., 1997. Covalent attachment of 4-Hydroxy-2-nonenal to erythrocyte proteins. The journal of biochemistry, 22, 1246–1251.
  • Vorou, R., Pierroutsakos, I.N., and Maltezou, H.C., 2007. Crimean-Congo hemorrhagic fever. Current opinion in infectious diseases, 20, 495–500.
  • Whitehouse, C.A., 2004. Crimean-Congo hemorrhagic fever. Antiviral research, 64, 145–160.
  • Winyard, P.G., et al., 2011. Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochemical society transactions, 39, 1226–1232.
  • Yagi, K., 1994. Lipid peroxides and related radicals in clinical medicine. In: Armstrong, D, ed. Free radicals in diagnostic medicine. Berlin, Germany: Plenum Press, 1–15.
  • Yilmaz, G., et al., 2010. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: Severity prediction criteria. Journal of clinical virology, 47, 361–365.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.